These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 31550677)

  • 1. LINC00339 promotes cell proliferation, migration, and invasion of ovarian cancer cells via miR-148a-3p/ROCK1 axes.
    Pan L; Meng Q; Li H; Liang K; Li B
    Biomed Pharmacother; 2019 Dec; 120():109423. PubMed ID: 31550677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LINC00339 regulates ROCK1 by miR-152 to promote cell proliferation and migration in hepatocellular carcinoma.
    Chen K; Zhang L
    J Cell Biochem; 2019 Sep; 120(9):14431-14443. PubMed ID: 31081143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA PVT1 facilitates cell migration and invasion by regulating miR-148a-3p and ROCK1 in breast cancer.
    Li HL; Wang CP; Zhang Y; Du JX; Han LH; Yang HY
    Clin Transl Oncol; 2022 May; 24(5):882-891. PubMed ID: 34859371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA SNHG20 promotes migration and invasion of ovarian cancer via modulating the microRNA-148a/ROCK1 axis.
    Yang Q; Dong YJ
    J Ovarian Res; 2021 Nov; 14(1):168. PubMed ID: 34836544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer.
    Zheng B; Liang L; Wang C; Huang S; Cao X; Zha R; Liu L; Jia D; Tian Q; Wu J; Ye Y; Wang Q; Long Z; Zhou Y; Du C; He X; Shi Y
    Clin Cancer Res; 2011 Dec; 17(24):7574-83. PubMed ID: 21994419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
    Shi J; Tan S; Song L; Song L; Wang Y
    Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA DANCR, working as a competitive endogenous RNA, promotes ROCK1-mediated proliferation and metastasis via decoying of miR-335-5p and miR-1972 in osteosarcoma.
    Wang Y; Zeng X; Wang N; Zhao W; Zhang X; Teng S; Zhang Y; Lu Z
    Mol Cancer; 2018 May; 17(1):89. PubMed ID: 29753317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA DLEUI promotes papillary thyroid carcinoma progression by sponging miR-421 and increasing ROCK1 expression.
    Li R; Wan T; Qu J; Yu Y; Zheng R
    Aging (Albany NY); 2020 Sep; 12(20):20127-20138. PubMed ID: 32910787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LINC00339 promotes gastric cancer progression by elevating DCP1A expression via inhibiting miR-377-3p.
    Shi C; Liu T; Chi J; Luo H; Wu Z; Xiong B; Liu S; Zeng Y
    J Cell Physiol; 2019 Dec; 234(12):23667-23674. PubMed ID: 31188482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of long noncoding RNA TUSC7 promoted cell growth, invasion and migration through sponging with miR-616-5p/GSK3β pathway in ovarian cancer.
    Zhu LM; Li N
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7253-7265. PubMed ID: 32706063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA
    Zhao H; Xiao H; Lu Y; Liu S; Wang C
    Cell Cycle; 2020 May; 19(10):1143-1157. PubMed ID: 32308105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINC00852 promotes the proliferation and invasion of ovarian cancer cells by competitively binding with miR-140-3p to regulate AGTR1 expression.
    Qiao ZW; Jiang Y; Wang L; Wang L; Jiang J; Zhang JR; Mu P
    BMC Cancer; 2021 Sep; 21(1):1004. PubMed ID: 34496800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LINC00339 promotes cell proliferation and metastasis in pancreatic cancer via miR-497-5p/IGF1R axis.
    Zhang R; Hao S; Yang L; Xie J; Chen S; Gu G
    J BUON; 2019; 24(2):729-738. PubMed ID: 31128030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA CASC9 promotes LIN7A expression via miR-758-3p to facilitate the malignancy of ovarian cancer.
    Hu X; Li Y; Kong D; Hu L; Liu D; Wu J
    J Cell Physiol; 2019 Jul; 234(7):10800-10808. PubMed ID: 30537154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA Linc00339 promotes triple-negative breast cancer progression through miR-377-3p/HOXC6 signaling pathway.
    Wang X; Chen T; Zhang Y; Zhang N; Li C; Li Y; Liu Y; Zhang H; Zhao W; Chen B; Wang L; Yang Q
    J Cell Physiol; 2019 Aug; 234(8):13303-13317. PubMed ID: 30618083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LINC00452 promotes ovarian carcinogenesis through increasing ROCK1 by sponging miR-501-3p and suppressing ubiquitin-mediated degradation.
    Yang J; Wang WG; Zhang KQ
    Aging (Albany NY); 2020 Nov; 12(21):21129-21146. PubMed ID: 33168781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DANCR promotes HCC progression and regulates EMT by sponging miR-27a-3p via ROCK1/LIMK1/COFILIN1 pathway.
    Guo D; Li Y; Chen Y; Zhang D; Wang X; Lu G; Ren M; Lu X; He S
    Cell Prolif; 2019 Jul; 52(4):e12628. PubMed ID: 31038266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNA AC005224.4/miR-140-3p/SNAI2 regulating axis facilitates the invasion and metastasis of ovarian cancer through epithelial-mesenchymal transition.
    Xiong T; Wang Y; Zhang Y; Yuan J; Zhu C; Jiang W
    Chin Med J (Engl); 2023 May; 136(9):1098-1110. PubMed ID: 36939239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA-148a-3p enhances the effects of sevoflurane on hepatocellular carcinoma cell progression via ROCK1 repression.
    Sun Y; Liu L; Xing W; Sun H
    Cell Signal; 2021 Jul; 83():109982. PubMed ID: 33741494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis.
    Yang X; Xin N; Qu HJ; Wei L; Han Z
    Anat Rec (Hoboken); 2020 Dec; 303(12):3024-3034. PubMed ID: 31930662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.